Zhang Chengcheng, Zhang Zhengxing, Zeisler Jutta, Colpo Nadine, Lin Kuo-Shyan, Bénard François
Department of Molecular Oncology, BC Cancer, 675 W 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada.
Department of Radiology, University of British Columbia, 2775 Laurel Street, Vancouver, British Columbia V5Z 1M9, Canada.
ACS Omega. 2020 May 7;5(19):10767-10773. doi: 10.1021/acsomega.0c00310. eCollection 2020 May 19.
In this study, we designed and evaluated a novel α-melanocyte-stimulating hormone derivative with four -methylations for melanocortin 1 receptor-targeted melanoma imaging with positron emission tomography (PET). The resulting peptide, DOTA-Pip-Nle-Cyclo[Asp--Me-His-d-Phe--Me-Arg--Me-Trp--Me-Lys]αMSH-NH (CCZ01099), showed high receptor selectivity, greatly improved stability, and rapid internalization. [Ga]Ga-CCZ01099 showed clear tumor visualization and excellent tumor-to-normal tissue contrast with PET imaging in a preclinical melanoma model. Therefore, CCZ01099 is a promising compound for imaging and potentially radioligand therapy for melanoma.
在本研究中,我们设计并评估了一种具有四个甲基化修饰的新型α-黑素细胞刺激激素衍生物,用于正电子发射断层扫描(PET)靶向黑素皮质素1受体的黑色素瘤成像。所得肽DOTA-Pip-Nle-Cyclo[Asp--Me-His-d-Phe--Me-Arg--Me-Trp--Me-Lys]αMSH-NH(CCZ01099)表现出高受体选择性、显著提高的稳定性和快速内化。[Ga]Ga-CCZ01099在临床前黑色素瘤模型的PET成像中显示出清晰的肿瘤可视化和出色的肿瘤与正常组织对比度。因此,CCZ01099是一种有前景的用于黑色素瘤成像及潜在放射性配体治疗的化合物。